• Thu. Feb 29th, 2024

Depixus Wins SLAS Ignite Award for MAGNA Technology Revolutionizing Interactomics


Feb 12, 2024
Depixus receives the Ignite Award at SLAS2024 for its MAGNA™ technology

Depixus, a leader in the field of intereactomics, has received the prestigious SLAS Ignite Award for their groundbreaking MAGNA™ technology at the annual International Conference and Exhibition in Boston, MA. The award was presented at the same time as the unveiling of Depixus’ MAGNA One™ instrument at the conference.

The Ignite Award is given to companies that are transforming the life sciences through innovative technologies. Depixus was one of just 16 companies selected to participate in the SLAS2024 Innovation AveNEW program, a dedicated area for start-ups and emerging companies within the conference. From these 16 companies, eight were chosen as finalists for the Ignite Award.

MAGNA One is based on magnetic force spectroscopy and offers high-throughput analysis of dynamic biomolecular interactions. This technology is unique in that it provides real-time measurements from thousands of individual molecules simultaneously, making it particularly valuable for exploring challenging targets such as RNA and protein-protein interactions. The insights gained from this technology can accelerate the development of novel therapeutics and improve our understanding of disease mechanisms.

Depixus CEO Gordon Hamilton expressed his enthusiasm about winning the Ignite Award, emphasizing how their innovative technology has the potential to impact diseases where new treatments are urgently needed. Chief Commercial Officer Steve Klose added that this momentous occasion coincides with Depixus’ technology access program launch and commercial rollout of MAGNA One, marking a significant milestone for their company.

For more information on Depixus and their MAGNA One instrument, visit depixus.com or contact Steve Klose at steve.klose@depixus.com

Leave a Reply